Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Disseminated growth of a human multiple myeloma cell line in mice with severe combined immunodeficiency disease.

Cancer research - 15 Mar 1993

Huang Y W, Richardson J A, Tong A W, Zhang B Q, Stone M J, Vitetta E S

Abstract excerpt

We have successfully engrafted a human multiple myeloma cell line, ARH-77, into C.B. 17 SCID mice. When ARH-77 cells were injected s.c., tumors grew only at the site of inoculation (five of five). When ARH-77 cells were injected i.v. tumors did not grow in any of the mice (zero of five). However, when mice were given gamma-irradiation with 150 rads and then inoculated i.v. with 10(7) ARH-77 cells, 100% (13 of 13)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Models, Animal
Share to Flow Cytometry

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunoglobulins

Share to Neoplasm Transplantation

Share to Nucleic Acid Hybridization

Share to Phenotype

Share to Tumor Cells, Cultured

Source

Identifiers

PMID: 8443818

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Disseminated growth of a human multiple myeloma cell line in mice with severe combined immunodeficiency disease.PMID 8443818Read ↗

Development of an orthotopic SCID mouse-human tumor xenograft model displaying the multidrug-resistant phenotype.Semantic proximity Read ↗

Interleukin-18 inhibits lodging and subsequent growth of human multiple myeloma cells in the bone marrow.Semantic proximity Read ↗

Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myelomaSemantic proximity Read ↗

NF-κB2 mutation targets survival, proliferation and differentiation pathways in the pathogenesis of plasma cell tumors.Semantic proximity Read ↗

The SCID-rab model: a novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cellsSemantic proximity Read ↗

The role of human herpesvirus-8, (HHV-8), in multiple myeloma pathogenesis.Semantic proximity Read ↗

LAGλ-1: A clinically relevant drug resistant human multiple myeloma tumor murine model that enables rapid evaluation of treatments for multiple myelomaSemantic proximity Read ↗

Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myelomaSemantic proximity Read ↗

An unusual H-Ras mutant isolated from a human multiple myeloma line leads to transformation and factor-independent cell growth.Semantic proximity Read ↗

Enhancement of clonogenicity of human multiple myeloma by dendritic cells.Semantic proximity Read ↗

Development of new adherent mutant from human myeloma-derived cell line: in vitro model of anaplastic transformation of myeloma.Semantic proximity Read ↗

The 5TMM series: a useful in vivo mouse model of human multiple myelomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.